Last updated: 8 August 2022 at 7:21am EST

Jean-Michel Halfon Net Worth




The estimated Net Worth of Jean Michel Halfon is at least $1.46 Million dollars as of 14 June 2022. Mr. Halfon owns over 14,479 units of Teva- Pharmaceutical Industries stock worth over $1,144,178 and over the last 6 years he sold TEVA stock worth over $0. In addition, he makes $320,452 as Independent Director at Teva- Pharmaceutical Industries.

Mr. Halfon TEVA stock SEC Form 4 insiders trading

Jean has made over 5 trades of the Teva- Pharmaceutical Industries stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 14,479 units of TEVA stock worth $260,043 on 14 June 2022.

The largest trade he's ever made was exercising 17,621 units of Teva- Pharmaceutical Industries stock on 11 June 2020 worth over $316,473. On average, Jean trades about 4,897 units every 61 days since 2018. As of 14 June 2022 he still owns at least 63,707 units of Teva- Pharmaceutical Industries stock.

You can see the complete history of Mr. Halfon stock trades at the bottom of the page.





Jean-Michel Halfon biography

Jean-Michel Halfon is Independent Director of the Company. he currently serves as an independent consultant, providing consulting services to pharmaceutical, distribution, healthcare IT and R&D companies. From 2008 to 2010, Mr. Halfon served as President and General Manager of Emerging Markets at Pfizer Inc., after serving in various senior management positions since 1989. From 1987 to 1989, Mr. Halfon served as Director of Marketing in France for Merck & Co., Inc.

What is the salary of Jean Halfon?

As the Independent Director of Teva- Pharmaceutical Industries, the total compensation of Jean Halfon at Teva- Pharmaceutical Industries is $320,452. There are 16 executives at Teva- Pharmaceutical Industries getting paid more, with Kaare Schultz having the highest compensation of $11,596,600.



How old is Jean Halfon?

Jean Halfon is 68, he's been the Independent Director of Teva- Pharmaceutical Industries since 2014. There are 2 older and 27 younger executives at Teva- Pharmaceutical Industries. The oldest executive at Teva- Pharmaceutical Industries Ltd. is Gerald Lieberman, 73, who is the Independent Director.

What's Jean Halfon's mailing address?

Jean's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, L3, 6944020.

Insiders trading at Teva- Pharmaceutical Industries

Over the last 7 years, insiders at Teva- Pharmaceutical Industries have traded over $31,332,399 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 . The most active insiders traders include Sol J Barer, Tal Zvi Zaks, and Roberto Mignone. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 9 days with the average trade being worth of $636,538. The most recent stock trade was executed by Varda Shalev on 2 September 2024, trading 12,872 units of TEVA stock currently worth $231,181.



What does Teva- Pharmaceutical Industries do?

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.



What does Teva- Pharmaceutical Industries's logo look like?

Teva- Pharmaceutical Industries Ltd. logo

Complete history of Mr. Halfon stock trades at Teva- Pharmaceutical Industries

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
14 Jun 2022 Jean Michel Halfon
Director
Option 14,479 $7.85 $113,660
14 Jun 2022
63,707
9 Jun 2021 Jean Michel Halfon
Director
Option 12,668 $10.73 $135,928
9 Jun 2021
49,228
5 Jun 2021 Jean Michel Halfon
Director
Option 6,041 $10.40 $62,826
5 Jun 2021
36,560
11 Aug 2020 Jean Michel Halfon
Director
Option 7,956 $11.72 $93,244
11 Aug 2020
30,519
11 Jun 2020 Jean Michel Halfon
Director
Option 17,621 $11.33 $199,646
11 Jun 2020
22,563


Teva- Pharmaceutical Industries executives and stock owners

Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: